CIK 0002044725
- Emerging growth company
Evommune, Inc.
Sign in to watch- Ticker
- EVMN
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 850742575
- Phone
- +1 650-223-7745
- Business address
- 1891 PAGE MILL RD, PALO ALTO, CA
- 4 Open-market buy Director bought 1,250,000 shares at $16.00 ($20,000,000)
- 4 Open-market buy 10% owner bought 1,562,500 shares at $16.00 ($25,000,000)
- 4 Open-market buy Director bought 1,562,500 shares at $16.00 ($25,000,000)
- 4 Conversion President & CEO acquired 24,225 shares (conversion)
- 4 Conversion Chief Scientific Officer acquired 3,175 shares (conversion)
- 4 Conversion Chief Business & Legal Officer acquired 3,175 shares (conversion)
- 4 Conversion Director acquired 3,371,001 shares (conversion)
- 4 Conversion EVP, Operations acquired 1,587 shares (conversion)
- 4 Conversion Director acquired 6,056 shares (conversion)
- 4 Conversion Chief Financial Officer acquired 3,175 shares (conversion)
- 4 Conversion Chief Medical Officer acquired 25,812 shares (conversion)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
Page 3 of 4 · 74 filings